PH News

September 9, 2020September 9, 2020

Milrinone Plus Sildenafil Improved Outcomes in Newborns With Persistent PH, Compared to Individual Treatments

News, PH News

Using sildenafil and milrinone together proved more effective than either therapy alone in treating newborns with severe persistent pulmonary hypertension (PH), a recent clinical study indicates. This combo treatment ... Read more

September 2, 2020September 2, 2020

High Mortality Rates Found for Premature Babies With BPD-PH Despite Therapies

News, PH News

Despite current targeted therapies, premature babies with bronchopulmonary dysplasia or BPD — a disease in which the lungs become irritated and fail to develop properly, causing breathing difficulties — ... Read more

August 26, 2020August 26, 2020

Adiponectin a Potential New Biomarker of Congenital Heart Disease in PH

News, PH News

High levels of the peptide adiponectin show potential as a biomarker for the prognosis of congenital heart disease in patients with pulmonary hypertension (PH), according to a recent study. Titled ... Read more

August 21, 2020August 21, 2020

FDA Reviewing Application for Tyvaso as Treatment for PH-ILD

News, PH News

The U.S. Food and Drug Administration (FDA) has accepted for review the application for Tyvaso (inhaled treprostinil) as a potential treatment for pulmonary hypertension associated with interstitial lung disease (PH-ILD). The ... Read more

July 31, 2020July 31, 2020

Klotho Protein Supplements Improve Pulmonary, Cardiac Function in BPD Rat Model

News, PH News

Preterm babies with the lung condition bronchopulmonary dysplasia (BPD) — a risk factor for the development of pulmonary hypertension (PH) — have lower levels of the anti-aging-associated protein Klotho, ... Read more

July 24, 2020July 24, 2020

Patient Advocate in Latin America Wins Team PHenomenal Hope Research Grant

News, PH News

Paula Menezes has been awarded a $50,000 PHenomenal Impact Fund for Global PH Research grant to identify challenges faced by pulmonary hypertension (PH) patients and caregivers in parts of ... Read more

July 1, 2020August 28, 2020

Tyvaso Improves Exercise Capacity of PH Patients in Group 3 WHO Classification, Data Show

News, PH News

Tyvaso (inhaled treprostinil) significantly improved the exercise capacity of people with World Health Organization (WHO) Group 3 pulmonary hypertension associated with interstitial lung disease (PH-ILD), achieving its primary endpoint ... Read more

June 24, 2020June 24, 2020

Newborns Seen at PH Risk if Fetal Growth Poor and Meconium Inhaled at Birth

News, PH News

Newborns were seen to be at an increased risk of pulmonary hypertension (PH) if they developed poorly while in the womb and had meconium aspiration syndrome, meaning they inhaled their ... Read more

June 12, 2020June 12, 2020

CAR Peptide Improves Remodulin Efficacy in PH Rat Model

News, PH News

CAR peptide (CAR), Vascular BioSciences’ lead therapeutic peptide candidate for pulmonary hypertension (PH) and other disorders, was found to increase the efficacy of Remodulin (treprostinil) at reducing clinical signs of ... Read more

June 5, 2020September 8, 2020

Bayer Offering Grants Up to $1M to Advance PAH, CTEPH Research and Care

CTEPH News, News, PAH News, PH News

Bayer has opened its second annual Pulmonary Hypertension Accelerated Bayer (PHAB) Awards, a grant funding program to support clinical research projects into pulmonary hypertension (PH), particularly those focused on pulmonary ... Read more